TRELLIS BIOSCIENCE, INC.

Harnessing the Human Immune System

Redwood City, United States · Founded 2015 · $19.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$19.0M
Last Round
$9.0M GrantJul 2026
Rounds
4

About

Trellis Bioscience is a clinical-stage biotechnology company that uses its proprietary CellSpot™ technology to discover rare, naturally optimized human monoclonal antibodies from healthy donor blood. The company targets infectious diseases and cancer with therapeutics that are safer and more effective due to their human origin. Trellis has derived five mAb therapeutic candidates with demonstrated superior binding affinity and broad-spectrum capabilities.

Summary

TRELLIS BIOSCIENCE, INC. is a Biotech company based in Redwood City, United States, founded in 2015. It has raised $19.0M in total across 4 rounds, most recently a $9.0M Grant round in Jul 2026. Investors include CARB-X and National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CJul 2026
$9.0M

Sign up to see all 4 rounds

Grant through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TRELLIS BIOSCIENCE, INC. on Indexed.vc
<a href="https://indexed.vc/companies/trellis-bioscience-inc"><img src="https://indexed.vc/api/badge/company/trellis-bioscience-inc" alt="TRELLIS BIOSCIENCE, INC. on Indexed.vc" width="260" height="76" /></a>